Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05644457
Exploratory Study of Early Biomarkers Allowing Dynamic Assessment of Response to Treatment in Cancers of the Head and Neck
Sponsor: Royal Marsden NHS Foundation Trust
View on ClinicalTrials.gov
Summary
DART is an exploratory molecular analysis study to assess potential early biomarkers of treatment response in squamous cell carcinoma of the head and neck (HNSCC)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2022-03-09
Completion Date
2026-04
Last Updated
2024-08-09
Healthy Volunteers
No
Conditions
Interventions
GENETIC
Circulating tumour DNA dynamics
Circulating tumour DNA (ctDNA) can be identified in patients with a wide variety of cancers and has been shown to allow early prediction of disease relapse after treatment with curative intent in HNSCC.
Locations (1)
The Royal Marsden Hospital
London, United Kingdom